Facebook
Toll-free:1-888-852-8623

All categories

  • All categories
  • Flow Cytometry Antibodies
  • ELISA Kits
  • MACS Cell Isolation
  • Antibodies and Reagents
  • Apoptosis and Cell Health Detection
  • Metabolism Assays
  • Immunoassays
  • Cell Identification Kits
  • Proteins and Peptides
  • Cell Culture
Please enter the item number/product keyword!
Keyword cannot be empty !
INSERT SYMBOLS:
  • α
  • β
  • γ
  • δ
  • ε
  • ζ
  • η
  • θ
  • κ
  • μ
  • ω
  • σ
  • τ
  • λ
  • ⅩⅢ
  • ⅩⅢ
  • ⅩⅣ
  • ⅩⅤ
  • ⅩⅦ
  • ⅩⅧ
  • UP ↑

Recombinant Phospho-IκBα (Ser36) Monoclonal Antibody (AN302095L)

Recombinant Phospho-IκBα (Ser36) Monoclonal Antibody - 1
  • Recombinant Phospho-IκBα (Ser36) Monoclonal Antibody - 1
  • Recombinant Phospho-IκBα (Ser36) Monoclonal Antibody - 2
All Size Price Qty
100μL $ 380.00
- +
50μL $ 249.00
- +
Add to cart

For research use only.

Verified Samples Verified Samples in WB: HeLa
Dilution WB 1:1000-2000
Isotype IgG, κ
Host Rabbit
Reactivity Human,  Mouse
Applications WB
Clonality Monoclonal;Recombinant
Immunogen Phosphorylated human IκBα (Ser36) peptide
Abbre Phospho-IκBα (Ser36)
Synonyms EDAID,  MAD,  IKBA,  MAD-3,  NFKBI,  IKB alpha,  NFKBIA,  EDAID2,  I kappa B alpha,  IkappaBalpha,  I-kappa-B-alpha,  IKBalpha,  IkB-alpha,  MAD 3,  NF kappa B inhibitor alpha,  MAD3,  alpha,  Major histocompatibility complex enhancer-binding protein MAD3,  NF-kappa-B inhibitor alpha,  Nuclear factor of kappa light chain gene enhancer in B cells,  Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor alpha,  nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor,  pIκBα
Swissprot
Calculated MW 36 kDa
Observed MW 39 kDa
The actual band is not consistent with the expectation.

Western blotting is a method for detecting a certain protein in a complex sample based on the specific binding of antigen and antibody. Different proteins can be divided into bands based on different mobility rates. The mobility is affected by many factors, which may cause the observed band size to be inconsistent with the expected size. The common factors include:

1. Post-translational modifications: For example, modifications such as glycosylation, phosphorylation, methylation, and acetylation will increase the molecular weight of the protein.

2. Splicing variants: Different expression patterns of various mRNA splicing bodies may produce proteins of different sizes.

3. Post-translational cleavage: Many proteins are first synthesized into precursor proteins and then cleaved to form active forms, such as COL1A1.

4. Relative charge: the composition of amino acids (the proportion of charged amino acids and uncharged amino acids).

5. Formation of multimers: For example, in protein dimer, strong interactions between proteins can cause the bands to be larger. However, the use of reducing conditions can usually avoid the formation of multimers.

If a protein in a sample has different modified forms at the same time, multiple bands may be detected on the membrane.

Cellular Localization Cytoplasm, Nucleus
Concentration 1 mg/mL
Buffer PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
Purification Method Protein A purified
Research Areas Signal Transduction,  Epigenetics and Nuclear Signaling,  Cancer,  Immunology
Clone No. A819
Conjugation Unconjugated
Storage Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Shipping Ice bag
background The NF-κB/Rel transcription factors are present in the cytosol in an inactive state complexed with the inhibitory IκB proteins. Activation occurs via phosphorylation of IκBα at Ser32 and Ser36 followed by proteasome-mediated degradation that results in the release and nuclear translocation of active NF-κB. IκBα phosphorylation and resulting Rel-dependent transcription are activated by a highly diverse group of extracellular signals including inflammatory cytokines, growth factors, and chemokines. Kinases that phosphorylate IκB at these activating sites have been identified.
Other Clones

{{antibodyDetailsPage.numTotal}} Results

Other Formats

{{formatDetailsPage.numTotal}} Results

Unconjugated

  • IF:{{item.impact}}

    Journal:{{item.journal}} ({{item.year}})

    DOI:{{item.doi}}

    Reactivity:{{item.species}}

    Sample Type:{{item.organization}}

  • Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}

Product Information